Cognitive function in recovered COVID-19 Lebanese patients with schizophrenia

Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med. 2020;38(7):1549.e1543-1549.e1547.

Article  Google Scholar 

Dinakaran D, Manjunatha N, Kumar CN, Suresh BM. Neuropsychiatric aspects of COVID-19 pandemic: a selective review. Asian J Psychiatr. 2020;53: 102188.

Article  PubMed  PubMed Central  Google Scholar 

Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-León J, Ray BK. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2020. https://doi.org/10.1017/cjn.2020.173.

Article  PubMed  PubMed Central  Google Scholar 

Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurol Sci. 2020;41:1667–71.

Article  PubMed  PubMed Central  Google Scholar 

Burdick KE, Millett CE. The impact of COVID-19 on cognition in severe cases highlights the need for comprehensive neuropsychological evaluations in all survivors. Neuropsychopharmacology. 2021. https://doi.org/10.1038/s41386-021-00995-7.

Article  PubMed  PubMed Central  Google Scholar 

Lucchese G, Flöel A. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons. Autoimmun Rev. 2020;19(7): 102556.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol. 2020;27(9):1764–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, Mazibuko N, Williams SC, Barnby JM, Hellyer P. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39: 101044.

Article  PubMed  PubMed Central  Google Scholar 

Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive impairment after COVID-19—a review on objective test data. Front Neurol. 2021. https://doi.org/10.3389/fneur.2021.699582.

Article  PubMed  PubMed Central  Google Scholar 

Woo MS, Malsy J, Pöttgen J, Seddiq Zai S, Ufer F, Hadjilaou A, Schmiedel S, Addo MM, Gerloff C, Heesen C. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2(2):fcaa05.

Article  Google Scholar 

Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, Shi C, Hu S. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 2020;129:98–102.

Article  PubMed  PubMed Central  Google Scholar 

Miskowiak K, Johnsen S, Sattler S, Nielsen S, Kunalan K, Rungby J, Lapperre T, Porsberg C. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fond G, Nemani K, Etchecopar-Etchart D, Loundou A, Goff DC, Lee SW, Lancon C, Auquier P, Baumstarck K, Llorca P-M. Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: a systematic review and meta-analysis. JAMA Psychiat. 2021;78(11):1208–17.

Article  Google Scholar 

Roe K. The link between Toxoplasma gondii infections and higher mortality in COVID-19 patients having schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2021. https://doi.org/10.1007/s00406-021-01341-0.

Article  PubMed  PubMed Central  Google Scholar 

Kozloff N, Mulsant BH, Stergiopoulos V, Voineskos AN. The COVID-19 global pandemic: implications for people with schizophrenia and related disorders. Schizophr Bull. 2020;46(4):752–7.

Article  PubMed  PubMed Central  Google Scholar 

Bowie CR, Harvey PD. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat. 2006;2(4):531.

Article  PubMed  PubMed Central  Google Scholar 

Millan MJ, Agid Y, Brüne M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, DeRubeis RJ. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov. 2012;11(2):141–68.

Article  CAS  PubMed  Google Scholar 

MacKenzie NE, Kowalchuk C, Agarwal SM, Costa-Dookhan KA, Caravaggio F, Gerretsen P, Chintoh A, Remington GJ, Taylor VH, Müeller DJ. Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Front Psych. 2018;9:622.

Article  Google Scholar 

Canal-Rivero M, Barragán RC, García AR, Torres NG, Crespo-Facorro B, Ruiz-Veguilla M, IBIS Translational Psychiatry Group. Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population. Schizophr Res. 2021;229:53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haddad C, Salameh P, Hallit S, Obeid S, Haddad G, Clément J-P, Calvet B. Cross-cultural adaptation and validation of the Arabic version of the BACS scale (the brief assessment of cognition in schizophrenia) among chronic schizophrenic inpatients. BMC Psychiatry. 2021;21(1):1–12.

Article  Google Scholar 

WHO. Clinical management of COVID-19: interim guidance. Geneva: WHO; 2020.

Google Scholar 

Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho B-C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiat. 2010;67(3):255–62.

Article  CAS  PubMed  Google Scholar 

Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46(12):1481–6.

Article  CAS  PubMed  Google Scholar 

Haddad C, Salameh P, Hallit S, Sacre H, Clément J-P, Calvet B. Self-assessment of social cognition in a sample of Lebanese in-patients with schizophrenia. Schizophr Res Cogn. 2021;26: 100207.

Article  PubMed  PubMed Central  Google Scholar 

Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004;68(2–3):283–97.

Article  PubMed  Google Scholar 

Hallit S, Obeid S, Haddad C, Kazour F, Kazour G. Validation of the Arabic Version of the PANSS scale among Lebanese schizophrenic patients. J Psychopathol. 2017.

Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261.

Article  CAS  PubMed  Google Scholar 

Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry. 1993;163(S22):39–44.

Article  Google Scholar 

Hani Y, Ghuloum S, Mahfoud Z, Opler M, Khan A, Yehya A, Abdulhakam A, Hammoudeh S, Al-Mujalli A, Elsherbiny R. Validation of the Arabic version of Calgary depression scale for schizophrenia. PLoS ONE. 2016;11(9): e0162304.

Article  PubMed  PubMed Central  Google Scholar 

Katz S. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.

Article  CAS  PubMed  Google Scholar 

Nasser R, Doumit J. Validity and reliability of the Arabic version of activities of daily living (ADL). BMC Geriatr. 2009;9(1):11.

Article  PubMed  PubMed Central  Google Scholar 

Kim H-Y. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38(1):52–4.

Article  PubMed  PubMed Central  Google Scholar 

Katan M, Moon YP, Paik MC, Sacco RL, Wright CB, Elkind MS. Infectious burden and cognitive function: the Northern Manhattan Study. Neurology. 2013;80(13):1209–15.

Article  PubMed  PubMed Central  Google Scholar 

Strandberg TE, Pitkala KH, Linnavuori KH, Tilvis RS. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke. 2003;34(9):2126–31.

Article  PubMed  Google Scholar 

Tarter KD, Simanek AM, Dowd JB, Aiello AE. Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey. J Infect Dis. 2014;209(6):837–44.

Article  PubMed  Google Scholar 

Raper J, Kovacs-Balint Z, Mavigner M, Gumber S, Burke MW, Habib J, Mattingly C, Fair D, Earl E, Feczko E. Long-term alterations in brain and behavior after postnatal Zika virus infection in infant macaques. Nat Commun. 2020;11(1):1–12.

Article  Google Scholar 

Steinfeld B, Scott J, Vilander G, Marx L, Quirk M, Lindberg J, Koerner K. The role of lean process improvement in implementation of evidence-based practices in behavioral health care. J Behav Health Serv Res. 2015;42(4):504–18.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif